Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds RSS Feed PharmiWeb Candidate Blog RSS Feed PharmiWeb Client Blog


Press Release

Lannett Announces Resignation Of Mahendra Dedhiya, Ph.D., Chief Of Scientific Affairs

Posted on: 23 Sep 16

PHILADELPHIA, Sept. 22, 2016 /PRNewswire/ -- Lannett Company, Inc. (NYSE: LCI) today announced the resignation of its chief of scientific affairs, Mahendra Dedhiya, Ph.D., effective October 21, 2016. 

"Mahendra joined Lannett last year as part of our acquisition of Silarx Pharmaceuticals," said Arthur Bedrosian, chief executive officer of Lannett.  "He intends to become a faculty member and researcher at Long Island University, where he had been teaching part time.  We thank him for his service to Lannett and wish him well." 

The company said a search is underway for a new head of research and development.

About Lannett Company, Inc.:
Lannett Company, founded in 1942, develops, manufactures, packages, markets and distributes generic pharmaceutical products for a wide range of medical indications.  For more information, visit the company's website at


Robert Jaffe


Robert Jaffe Co., LLC


(424) 288-4098

For more information:

Editor's Details

Mike Wood

Last updated on: 23/09/2016

Share | | |
Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.